We work with our clients to develop and implement testing approaches that integrate animal disease models and human tissue assays.

We can apply our animal models and standardised assays for human peripheral blood analysis, pharmacodynamics and pharmacokinetics.

Our leadership and advisory teams are trusted, world-renowned experts in a range of fields, with combined expertise in immunology, endocrinology, animal models of diabetes and genomics. We have a proven track record in clinical translation, which encompasses onsite human islet isolation and transplantation, biobanking and clinical trials

Our services

  • We consult

    We see ourselves as more than service providers. We are your partners – treating your projects as if they were our own. We work with you to design experiments that will deliver valuable insights and reach critical milestones on time and on budget.

    Effica Biolabs has close networks with other recommended service providers with whom we can partner to complement and expand your experimental design and testing needs.

    We test

    Our team has a depth of experience testing different types of therapeutics in animal models and human tissue. Our established suite of models, assays and data analysis expertise, in combination with state-of-the-art facilities and technology platforms, means we can offer both proof-of-concept and larger, more complex experiments to test your therapies.

    We deliver

    Through a collaborative, seamless process, we generate data to address your specific requirements. We provide reliable results that will help identify the best ‘next step’ for your project – whether that be scientific publications, clinical trials or regulatory submissions.

    Effica Biolabs team members

    Leadership & Scientific Consulting Team

    Founding Scientific Director (2020 – 2024d):  Prof Helen Thomas, PhD

    Chief Operations Officer:  Dr Tom Brodnicki, PhD

    Commercialisation Lead:  Dr Christopher Meoli, PhD

    Prof Tom Kay, BMedSci, MBBS, PhD, FRACP, FRCPA

    A/Prof Stuart Mannering, PhD

    Dr Tom Loudovaris, PhD

    Dr Michaela Waibel, PhD

     

    Expert Technical Team

    Dr Gaurang Jhala, PhD

    Dr Prerak Trivedi, PhD

    Mr Jarrod Skinner, BSc (Hons)

    Mr Sam McNeil, BSc (Hons)

    Mr Jack Murphy, BSc

    Ms Viki Moshovakis, Dip Appl Sci

    Ms Tara Catterall, Dip Appl Sci

    Ms Lorainne Elkerbout, Dip Appl Sci

    Our Partners

    Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) 

    ATIC’s mission is to accelerate the delivery of immunotherapy for type 1 diabetes.  ATIC aims to accomplish this by working across six distinct but interconnected domains:  Clinical Trials, Regulation & Government, Education & Training, Data Management, and Preclinical & Translation.  The ATIC Preclinical and Translation team works closely with Effica Biolabs to offer an extensive range of preclinical and clinical trial services.

    Click HERE for more info about ATIC.

     

     

Vale Professor Helen Thomas

It is with great sadness that we announce the death of Professor Helen Thomas, an outstanding medical researcher, colleague and mentor who was the founder of Effica Biolabs and whose work in type 1 diabetes made a significant impact. Our thoughts are with her family and wide network of friends and colleagues.


Vale Professor Helen Thomas

Effica Biolabs is listed on the Therapeutic Innovation Australia (TIA) Pipeline Navigator.